Evaluate the Efficacy and Safety of ID1201 for Dose-finding in Mild Alzheimer's Disease

A Safety and Tolerability Evaluation of Two 10-Week Dose Regimens of Orally-Administered PF-04494700 in Alzheimer's Patients

NCT00141661 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety Study of DCB-AD1 in Patients With Mild to Moderate Alzheimer's Disease

NCT00154635 ·Status: UNKNOWN ·Phase: PHASE2

Study to Evaluate the Efficacy and Safety of GSK239512 in Alzheimer's Disease

NCT01009255 ·Status: COMPLETED ·Phase: PHASE2

A Phase I [18F]THK-5351 Positron Emission Tomography Study in Healthy Subjects and Alzheimer's Disease

NCT03112096 ·Status: COMPLETED ·Phase: PHASE1

Dose-Finding Study To Evaluate Safety, Tolerability, and Efficacy of E2609 in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (Prodromal Alzheimer's Disease) and Mild to Moderate Dementia Due to Alzheimer's Disease

NCT02322021 ·Status: TERMINATED ·Phase: PHASE2

Efficacy and Safety of ChOline ALfoscerate in Patient With Mild to Moderate Alzheimer's Disease

NCT05383183 ·Status: RECRUITING ·Phase: PHASE4

A Phase I Study of DDN-A-0101 in Healthy Volunteers and Elder People

NCT06367426 ·Status: RECRUITING ·Phase: PHASE1

A Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-63733657 in Healthy Subjects and Subjects With Alzheimer's Disease

NCT03375697 ·Status: COMPLETED ·Phase: PHASE1

Clinical Trial of Donepezil Between the Naive Group and the Switching Group

NCT01023425 ·Status: COMPLETED ·Phase: NA

Safety and Efficacy of Donepezil in Mild to Moderate Alzheimer's Disease

NCT02787746 ·Status: COMPLETED ·Phase: PHASE4

Clinical Trial of Donepezil Between the Patients With Alzheimer's Disease and Mixed Dementia

NCT01023867 ·Status: COMPLETED ·Phase: NA

Post-marketing Surveillance of Long-term Administration of Donepezil Hydrochloride -Investigation of the Clinical Condition and Safety in Patients With Alzheimer's Disease-

NCT01129596 ·Status: COMPLETED

Efficacy, Safety and Tolerability of Tideglusib to Treat Mild-to-Moderate Alzheimer's Disease Patients

NCT01350362 ·Status: COMPLETED ·Phase: PHASE2

Multiple IV Dose Study Of PF-04360365 In Patients With Mild To Moderate Alzheimer's Disease

NCT00722046 ·Status: COMPLETED ·Phase: PHASE2

4 Week, Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's Disease

NCT01039701 ·Status: COMPLETED ·Phase: PHASE2

Clinical Trial of CT1812 in Mild to Moderate Alzheimer's Disease

NCT02907567 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Efficacy, Safety, & Tolerability of AZD3480 Patients With Mild to Moderate Dementia of the Alzheimer's Type (AD)

NCT01466088 ·Status: COMPLETED ·Phase: PHASE2

MK0249 for the Symptomatic Treatment of Alzheimer's Disease (MK0249-011)

NCT00420420 ·Status: COMPLETED ·Phase: PHASE2

A Confirmatory Trial of SK-PC-B70M in Mild to Moderate Alzheimer's Disease

NCT01249196 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease

NCT00663936 ·Status: COMPLETED ·Phase: PHASE2

The Efficacy, Safety, And Tolerability Of Donepezil HCl (E2020) In Patients With CADASIL Who Have Cognitive Impairment

NCT00103948 ·Status: COMPLETED ·Phase: PHASE2

Study of 50561 in Patients With Mild or Moderate Alzheimer's Disease

NCT05811442 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of the Safety and Potential Therapeutic Effects of CB-AC-02 in Patients With Alzheimer's Disease

NCT02899091 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Efficacy and Safety of 3 Doses of S47445 Versus Placebo in Patients With Alzheimer's Disease at Mild to Moderate Stages With Depressive Symptoms

NCT02626572 ·Status: COMPLETED ·Phase: PHASE2

Clinical Study Evaluating Efficacy and Safety of T3D-959 in Mild-to-moderate AD Subjects

NCT04251182 ·Status: COMPLETED ·Phase: PHASE2